Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Cancel
Pirfenidone Improves Idiopathic Pulmonary Fibrosis SurvivalPirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with antifibrotic agents, a study found.